But that's not the best reason to consider buying it.
News & Analysis: Viatris Inc.
On the hunt for bargains in today's overvalued market? Look no further.
Income-seeking investors will love these stocks with great dividends and attractive valuations.
It's been a rough start for the combined generic drug company.
The company released its guidance for its fiscal year 2021.
If people need Xanax in the future -- and they definitely will -- they'll need Viatris to make it.
Many investors appear to be overlooking the potential for this brand-new stock.
High dividend yields plus low valuations could be just the ticket for income-seeking investors.
It's no bull: These stocks are set to weather a potential storm.
All three also offer attractive dividends.